Appendix E. IRB approval letter_Jan2025

Appendix E

IRB approval letter

    Expedited Review Approved: IRB #2726 

 

To:	Caroline Lauver
Institution:	Mathematica Policy Research (MPR)
From:	HML IRB
Subject:	Study #2726
Date:	11/25/2024

 

Dear Caroline Lauver,

The protocol WIC & FMNP Outreach, Innovation, and Modernization Evaluation, 2726 was assessed through an expedited research ethics review by HML Institutional Review Board. This study’s human subjects’ protection protocols, as stated in the materials submitted, received research ethics review approval on 11/25/2024 in accordance with the requirements of the US Code of Federal Regulations for the Protection of Human Subjects (45CFR46 & 45CFR46.110) and were expedited by (7) Research on individual or group characteristics or behavior.

You may rely on this IRB for review and continuing ethical oversight of this study. You and your project staff remain responsible for ensuring compliance with HML IRB’s determinations. Those responsibilities include, but are not limited to: 1) ensuring prompt reporting to HML IRB of proposed changes in this study’s design, subject risks, informed consent, or other human protection protocols; 2) investigators will conduct the research activity in accordance with the terms of the IRB approval until any proposed changes have been reviewed and approved by the IRB, except when necessary to mitigate hazards to subjects; 3) and to promptly report any unanticipated problems involving risks to subjects or others in the course of this study.

The approval of your study is valid through 11/24/2025, by which time you must submit an annual check-in report either closing the study or requesting permission to continue for another year.  Please submit your report by 11/17/2025 so that the IRB has time to review and approve your report prior to the expiration date. For instructions on how to manage an approved study refer to: How to Manage an Approved Study.

Please note that we have changed our fee schedule for 2025. For details, please see 2025 HML IRB Fees.

HML IRB is authorized by the U.S. Department of Health and Human Services, Office of Human Research Protections (IRB #00001211, IORG #0000850), and has DHHS Federal-Wide Assurance approval (FWA #00001102).

If you have any questions, please contact us at [email protected].

Sincerely,

D. Michael Anderson PhD, MPH

IRB Chair & Human Research Protections Director

[email protected]

Health Media Lab, Inc.
1101 Connecticut Avenue, NW Suite 450  Washington, DC 20036  USA
+1 202.246.8504   [email protected]   www.HMLIRB.com